
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors is a strong buy due to its positive FFO growth outlook and low-levered balance sheet. The company's healthcare property type diversification, high exposure to private payment for services, and attractive dividend yield, make it a stable investment option. However, there are risks associated with high operator concentration and potential fluctuations in acquisition volumes and asset values. Overall, NHI has robust fundamentals and potential for above-average growth, making it an attractive long-term investment option.
Bears say
National Health Investors is facing several headwinds that could negatively impact its financial performance in the coming years. These include a lower FFO estimate due to gradual redeployment of disposition proceeds and increased leverage, lower than expected occupancy rates in its SHOP segment, and higher transaction costs related to the recent sale of its NHC portfolio. Additionally, the sale of the NHC portfolio, while addressing a long-standing issue, may have not been as advantageous as investors had hoped and may result in lost potential rent increases. Overall, the company's fundamentals and potential growth do not align with its current valuation, making it a negative outlook for the stock.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares